Skip to main content


FDA Panel: Two Thumbs Down for New Oral Testosterone Drugs

January 11, 2018

An FDA advisory committee voted 13-6 today against recommending the approval of the oral testosterone undecanoate capsule Tlando (Lipocine) for the treatment of hypogonadism in adult males.

Full story

Tagged Under:

Get the latest on healthcare leadership in your inbox.